These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38234607)

  • 1. The Potential and Application of iPSCs in Gene and Cell Therapy for Retinopathies and Optic Neuropathies.
    Lapshin EV; Gershovich YG; Karabelsky AV
    Acta Naturae; 2023; 15(4):56-64. PubMed ID: 38234607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of induced pluripotent stem cells for studying and treating optic neuropathies.
    Khan S; Hung SS; Wong RC
    Curr Opin Organ Transplant; 2016 Oct; 21(5):484-9. PubMed ID: 27517502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced Pluripotent Stem Cells for Inherited Optic Neuropathies-Disease Modeling and Therapeutic Development.
    Harvey JP; Sladen PE; Yu-Wai-Man P; Cheetham ME
    J Neuroophthalmol; 2022 Mar; 42(1):35-44. PubMed ID: 34629400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies.
    Lopez Sanchez MI; Crowston JG; Mackey DA; Trounce IA
    Pharmacol Ther; 2016 Sep; 165():132-52. PubMed ID: 27288727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotent Stem Cell-Based Approaches to Explore and Treat Optic Neuropathies.
    Rabesandratana O; Goureau O; Orieux G
    Front Neurosci; 2018; 12():651. PubMed ID: 30294255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary Optic Neuropathies: Induced Pluripotent Stem Cell-Based 2D/3D Approaches.
    García-López M; Arenas J; Gallardo ME
    Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33477675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal repair with induced pluripotent stem cells.
    Al-Shamekh S; Goldberg JL
    Transl Res; 2014 Apr; 163(4):377-86. PubMed ID: 24291154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary Optic Neuropathies: A Systematic Review on the Interplay between Biomaterials and Induced Pluripotent Stem Cells.
    Ladero M; Reche-Sainz JA; Gallardo ME
    Bioengineering (Basel); 2024 Jan; 11(1):. PubMed ID: 38247929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autosomal recessive optic neuropathies: genetic variants, clinical manifestations].
    Murakhovskaya YK; Sheremet NL; Shmelkova MS; Krylova TD; Tsygankova PG
    Vestn Oftalmol; 2022; 138(6):116-122. PubMed ID: 36573955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications.
    Fu L; Kwok SS; Chan YK; Ming Lai JS; Pan W; Nie L; Shih KC
    Biomed Res Int; 2019; 2019():8397521. PubMed ID: 31828134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanopsin retinal ganglion cells are resistant to neurodegeneration in mitochondrial optic neuropathies.
    La Morgia C; Ross-Cisneros FN; Sadun AA; Hannibal J; Munarini A; Mantovani V; Barboni P; Cantalupo G; Tozer KR; Sancisi E; Salomao SR; Moraes MN; Moraes-Filho MN; Heegaard S; Milea D; Kjer P; Montagna P; Carelli V
    Brain; 2010 Aug; 133(Pt 8):2426-38. PubMed ID: 20659957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a Transplantable Population of Human iPSC-Derived Retinal Ganglion Cells.
    Rabesandratana O; Chaffiol A; Mialot A; Slembrouck-Brec A; Joffrois C; Nanteau C; Rodrigues A; Gagliardi G; Reichman S; Sahel JA; Chédotal A; Duebel J; Goureau O; Orieux G
    Front Cell Dev Biol; 2020; 8():585675. PubMed ID: 33195235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically determined optic neuropathies.
    Milea D; Amati-Bonneau P; Reynier P; Bonneau D
    Curr Opin Neurol; 2010 Feb; 23(1):24-8. PubMed ID: 19915464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical Coherence Tomography of the Retinal Ganglion Cell Complex in Leber's Hereditary Optic Neuropathy and Dominant Optic Atrophy.
    Asanad S; Tian JJ; Frousiakis S; Jiang JP; Kogachi K; Felix CM; Fatemeh D; Irvine AG; Ter-Zakarian A; Falavarjani KG; Barboni P; Karanjia R; Sadun AA
    Curr Eye Res; 2019 Jun; 44(6):638-644. PubMed ID: 30649972
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene Therapy of Dominant CRX-Leber Congenital Amaurosis using Patient Stem Cell-Derived Retinal Organoids.
    Kruczek K; Qu Z; Gentry J; Fadl BR; Gieser L; Hiriyanna S; Batz Z; Samant M; Samanta A; Chu CJ; Campello L; Brooks BP; Wu Z; Swaroop A
    Stem Cell Reports; 2021 Feb; 16(2):252-263. PubMed ID: 33513359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches.
    Chun BY; Rizzo JF
    Semin Pediatr Neurol; 2017 May; 24(2):129-134. PubMed ID: 28941528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling autosomal dominant optic atrophy using induced pluripotent stem cells and identifying potential therapeutic targets.
    Chen J; Riazifar H; Guan MX; Huang T
    Stem Cell Res Ther; 2016 Jan; 7():2. PubMed ID: 26738566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in Gene Therapy to Prevent Retinal Ganglion Cell Loss in Glaucoma and Leber's Hereditary Optic Neuropathy.
    Ratican SE; Osborne A; Martin KR
    Neural Plast; 2018; 2018():7108948. PubMed ID: 29853847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical characteristics and research progress on the treatment of mitochondrial optic neuropathy].
    Guo ST; Jiang LB
    Zhonghua Yan Ke Za Zhi; 2021 May; 57(5):386-390. PubMed ID: 33915644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optic neuropathies: characteristic features and mechanisms of retinal ganglion cell loss.
    You Y; Gupta VK; Li JC; Klistorner A; Graham SL
    Rev Neurosci; 2013; 24(3):301-21. PubMed ID: 23612594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.